Macroaxis: Personalized Investing
Simple Personalized Investing

S&P 500   1,667   17.00  Index Moved Up 1.03%
JNJ PFE NVS SNY Government Macroaxis 30 Cleaning Recent Drops 
United States  USA  |  Macroaxis Daily Picks


Processing
Processing. Please wait...

Aegerion Market Capitalization

 
 Companies |  Insiders  | Dashboard  
     

Market Capitalization breakdown for Aegerion

Market Capitalization is total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.

Aegerion

Market Cap

=

Shares Outstanding

X

Share Price

=
1.75 B
In most publications or references market cap is broken down into the mega cap, large cap, mid cap, small cap, micro cap, and nano cap. Market Cap is a measurement of business as total market value of all of outstanding shares at a given time, and can be used to compare different companies based on their size.
Compare Aegerion to competition

Aegerion Market Capitalization Assessment

Based on recorded statements the market capitalization of Aegerion Pharmaceuticals Inc is about 1.75 B. This is 87.13% lower than that of Healthcare sector, and 98.12% lower than that of Drug Manufacturers - Major industry, The Market Capitalization for all stocks is 83.98% higher than the company.

Filter other Stocks by Market Capitalization

Specify Market Cap
Select Market Capitalization Range
Current Range 
Indicate Industry
Click to run this filter
 Run Equity Filter
Filter Other Equities
  
Aegerion Pharmaceuticals Inc is rated below average in market capitalization category among related companies. Market capitalization of Drug Manufacturers - Major industry is presently estimated at about 1.24 Trillion. Aegerion adds roughly 1.75 Billion in market capitalization claiming only tiny portion of equities under Drug Manufacturers - Major industry.
Follow Aegerion Market Capitalization with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Add To Reader
 
Add Aegerion to your reader
 
    
AEGR United States Nasdaq
Aegerion Pharmaceuticals Inc
Currency: USD - US Dollar
Traded on NASDAQ
    
    

Other Aegerion Fundamentals

Return On Equity(78.29) %
Return On Asset(39.85) %
Current Valuation1.18 B
Shares Outstanding28.34 M
Shares Owned by Insiders23.15 %
Shares Owned by Institutions74.80 %
Number of Shares Shorted3.19 M
Price to Earning771 times
Price to Book10.50 times
Revenue1.23 M
EBITDA(67.23 M)
Net Income(68.74 M)
Cash and Equivalents140.69 M
Cash per Share4.97 times
Total Debt10.27 M
Debt to Equity0.08 times
Current Ratio11.74 times
Book Value Per Share4.47 times
Cash Flow from Operations(42.56 M)
Short Ratio5.70 times
One Year High63.72
One Year Low12.87
Earnings Per Share(2.71) times
Price to Earnings To Growth0.29 times
Number of Employees98
Beta0.68
Market Capitalization1.75 B
Total Asset85.09 M
Retained Earnings(192.72 M)
Working Capital66.82 M
Current Asset83.75 M
Current Liabilities16.93 M
Z Score99.2
Probability Of Bankruptcy1.00 %


 
Analytics
Risk Adjusted Returns Landscape
Live Efficient Frontier
Market Correlation Analysis
Watchlist Analysis
Financial Content
Portfolio Estimation and Projections
Portfolio Theme Builder
 
 
Research Modules
Equities Backtesting Analysis
Instant Retirement Optimizer
Cross-portfolio RSS and Mobile Access
Company, fund, and ETF Directory
Financial Advisor Directory
Insider and Manager Directory
Wealth Management
 Gadgets, Widgets, and Apps          
  
 
Services And Technology
Frequently Asked Questions
Quick Product Tour
Product Technology Overview
Solution Methodology
Plans and Pricing
 
Free Investor Tools
World Market Correlations
Instant Equity Comparator
Watchlist Analysis
Position Suggestions
Equity Alpha Analysis
 
About Us
About Macroaxis
Contact Us
Product Terms Of Use
Service Privacy Policy
Advertising Opportunities
Content

Thanks for checking out Macroaxis

Tell us what you like and what you don't like. We promise we'll not only listen but write you back

Contact Us
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide. Please fill out our quick survey to help us provide your with a better service and user experience

Fill Out Quick Survey
Most of the functionality on our site is free to use. However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory

Go Premium